4.7 Article

Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

Joshua J. Solomon et al.

Summary: This study evaluated the safety, tolerability, and efficacy of pirfenidone for the treatment of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The results showed that although it did not meet the primary endpoint, pirfenidone slowed the rate of decline in lung function in patients with RA-ILD.

LANCET RESPIRATORY MEDICINE (2023)

Editorial Material Rheumatology

A call for evidence in connective tissue diseases-associated interstitial lung disease

Vincent Cottin et al.

JOINT BONE SPINE (2022)

Article Rheumatology

The impact of disease severity measures on survival in US Veterans with rheumatoid arthritis-associated interstitial lung disease

Rebecca Brooks et al.

Summary: The severity of RA and ILD is associated with survival in patients with RA-ILD. Monitoring the systemic features of RA-ILD has prognostic value.

RHEUMATOLOGY (2022)

Review Respiratory System

Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease

Scott Matson et al.

Summary: Although RA-ILD and IPF are distinct diseases, they share several clinical, radiographic, and genetic features, sparking interest in their relationship. Understanding the links between these diseases could fundamentally change strategies for the diagnosis, screening, and treatment of ILD.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Rheumatology

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts

Yoel Brito et al.

CURRENT RHEUMATOLOGY REPORTS (2017)

Article Respiratory System

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease

Joshua J. Solomon et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Cardiac & Cardiovascular Systems

Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease

Justin M. Oldham et al.

RESPIRATORY MEDICINE (2016)

Article Medicine, General & Internal

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

Ganesh Raghu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Critical Care Medicine

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference

Roland M. du Bois et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Respiratory System

Biological treatments and connective tissue disease associated interstitial lung disease

Stylianos T. Panopoulos et al.

CURRENT OPINION IN PULMONARY MEDICINE (2011)

Article Rheumatology

Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis

Tim Bongartz et al.

ARTHRITIS AND RHEUMATISM (2010)

Article Respiratory System

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease

E. J. Kim et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Letter Medicine, General & Internal

Rheumatoid arthritis interstitial lung disease: Mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug

Lcslcy Ann Saketkoo et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

Article Rheumatology

The epidemiology of rheumatoid arthritis

SE Gabriel

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2001)